|
HYOU1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.676010E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.559510E-03 |
| Normal-vs-Stage2 |
2.528800E-01 |
| Normal-vs-Stage3 |
4.646000E-01 |
| Normal-vs-Stage4 |
6.862400E-01 |
| Stage1-vs-Stage2 |
5.401000E-01 |
| Stage1-vs-Stage3 |
5.096300E-02 |
| Stage1-vs-Stage4 |
4.577900E-02 |
| Stage2-vs-Stage3 |
5.385200E-01 |
| Stage2-vs-Stage4 |
4.438200E-01 |
| Stage3-vs-Stage4 |
8.184000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.666300E-02 |
| Normal-vs-AfricanAmerican |
1.035290E-03 |
| Normal-vs-Asian |
1.762020E-01 |
| Caucasian-vs-AfricanAmerican |
4.576000E-02 |
| Caucasian-vs-Asian |
7.111000E-01 |
| AfricanAmerican-vs-Asian |
7.557200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.277500E-03 |
| Normal-vs-Female |
2.268000E-01 |
| Male-vs-Female |
9.807600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.206600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.433500E-02 |
| Normal-vs-Age(61-80Yrs) |
3.705700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.568160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.562400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.223000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.555000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.295400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.660400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.192200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.931000E-01 |
| Normal-vs-Grade 2 |
5.62769999999935E-05 |
| Normal-vs-Grade 3 |
3.106500E-02 |
| Normal-vs-Grade 4 |
9.665600E-02 |
| Grade 1-vs-Grade 2 |
2.326000E-01 |
| Grade 1-vs-Grade 3 |
7.229200E-01 |
| Grade 1-vs-Grade 4 |
6.430100E-02 |
| Grade 2-vs-Grade 3 |
3.180100E-02 |
| Grade 2-vs-Grade 4 |
1.954320E-04 |
| Grade 3-vs-Grade 4 |
4.798100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.162600E-04 |
| Normal-vs-ccB subtype |
7.352600E-01 |
| ccA subtype-vs-ccB subtype |
5.979600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.951800E-02 |
| Normal-vs-N1 |
3.645800E-01 |
| N0-vs-N1 |
2.015200E-01 |
|
|
